Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
The Journal of Clinical Investigation
|
February 14, 2012
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
Holbrook E Kohrt, Roch Houot, Kipp Weiskopf, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 28, 2012
Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma
Badreddin Edris, Kipp Weiskopf, Anne K Volkmer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2013
Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth
Badreddin Edris, Stephen B Willingham, Kipp Weiskopf, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2024
CD47 predominates over CD24 as a macrophage immune checkpoint in cancer
Juliet Allen, Anna Meglan, Kyle Vaccaro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 22, 2017
Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
Nan Guo Ring, Dietmar Herndler-Brandstetter, Kipp Weiskopf, et al.
Cancer Immunology Research
|
November 19, 2016
Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
Kipp Weiskopf, Katie L Anderson, Daisuke Ito, et al.
Immunity
|
May 21, 2015
Interleukin-2 activity can be fine tuned with engineered receptor signaling clamps
Suman Mitra, Aaron M Ring, Shoba Amarnath, et al.
Nature Immunology
|
November 29, 2017
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy
Amira A Barkal, Kipp Weiskopf, Kevin S Kao, et al.
Cell Reports
|
September 10, 2023
MMD collaborates with ACSL4 and MBOAT7 to promote polyunsaturated phosphatidylinositol remodeling and susceptibility to ferroptosis
Vaishnavi V Phadnis, Jamie Snider, Venkateshwari Varadharajan, et al.
The Journal of Clinical Investigation
|
May 20, 2014
Targeting CD137 enhances the efficacy of cetuximab
Holbrook E Kohrt, A Dimitrios Colevas, Roch Houot, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
The Journal of Clinical Investigation
|
February 14, 2012
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
Holbrook E Kohrt, Roch Houot, Kipp Weiskopf, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 28, 2012
Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma
Badreddin Edris, Kipp Weiskopf, Anne K Volkmer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2013
Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth
Badreddin Edris, Stephen B Willingham, Kipp Weiskopf, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2024
CD47 predominates over CD24 as a macrophage immune checkpoint in cancer
Juliet Allen, Anna Meglan, Kyle Vaccaro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 22, 2017
Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
Nan Guo Ring, Dietmar Herndler-Brandstetter, Kipp Weiskopf, et al.
Cancer Immunology Research
|
November 19, 2016
Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20
Kipp Weiskopf, Katie L Anderson, Daisuke Ito, et al.
Immunity
|
May 21, 2015
Interleukin-2 activity can be fine tuned with engineered receptor signaling clamps
Suman Mitra, Aaron M Ring, Shoba Amarnath, et al.
Nature Immunology
|
November 29, 2017
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy
Amira A Barkal, Kipp Weiskopf, Kevin S Kao, et al.
Cell Reports
|
September 10, 2023
MMD collaborates with ACSL4 and MBOAT7 to promote polyunsaturated phosphatidylinositol remodeling and susceptibility to ferroptosis
Vaishnavi V Phadnis, Jamie Snider, Venkateshwari Varadharajan, et al.
The Journal of Clinical Investigation
|
May 20, 2014
Targeting CD137 enhances the efficacy of cetuximab
Holbrook E Kohrt, A Dimitrios Colevas, Roch Houot, et al.
Page
of 5